Alcon to Acquire Aerie Pharmaceuticals for US$770 M

By Lucy Haggerty

Pharma Deals Review: Vol 2022 Issue 8 (Table of Contents)

Published: 26 Aug-2022

DOI: 10.3833/pdr.v2022.i8.2718     ISSN: 1756-7874

Section: Mergers & Acquisitions



In order to expand its presence in the ophthalmic pharmaceutical eye drop space, Alcon has entered into a definitive merger agreement with Aerie Pharmaceuticals through which Alcon will acquire Aerie for US$15...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details